143.65
-3.84 (-2.6%)
-3.84 (-2.6%)
Upgrade to Real-Time
Afterhours (Closed)
Low
134.51
High
213.94
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Seagen Inc | SGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -3.84 | -2.6% | 143.65 | 17:13:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 147.14 | 143.00 | 147.14 | 143.65 | 147.49 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 143.00 | 147.00 | 4.00 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,266 | 826,195 | $ 145.20 | $ 119,967,414 | 973,136 | 134.51 - 213.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:16:53 | 2 | $ 147.00 | USD |
Seagen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 25.71B | 179.00M | 60.40M | $ 916.71M | $ 260.07M | -0.95 | 71.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Seagen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 145.19 | 151.905 | 143.00 | 146.60 | 902,675 | -1.54 | -1.06% |
| 1 Month | 140.90 | 151.905 | 134.51 | 142.61 | 935,251 | 2.75 | 1.95% |
| 3 Months | 163.39 | 199.00 | 134.51 | 154.48 | 1,167,217 | -19.74 | -12.08% |
| 6 Months | 198.42 | 202.92 | 134.51 | 166.24 | 1,059,225 | -54.77 | -27.6% |
| 1 Year | 139.96 | 213.94 | 134.51 | 165.91 | 1,073,737 | 3.69 | 2.64% |
| 3 Years | 49.89 | 213.94 | 47.75 | 112.03 | 1,006,356 | 93.76 | 187.93% |
| 5 Years | 39.23 | 213.94 | 32.395 | 90.27 | 981,648 | 104.42 | 266.17% |
Seagen Description
| Seagen Inc is a biotech firm focused on developing antibody-drug conjugates. The company's lead product, Adcetris, has received approval for advanced front-line, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. Other approved products include Padcev (bladder cancer) and Tukysa (breast cancer). The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies. |
